Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interim Buprenorphine Treatment for Opioid Use Disorder Waitlists
NCT03420313Phase 2Unknown
- Sponsor
- The University of Vermont
- Start
- Mar 2018
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by The University of Vermont. Status: unknown.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03420313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03420313.